A Study to Show That Flutiform is Well Tolerated and Effective in the Treatment of COPD

NCT01946620 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1767

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Flutiform
DRUG: Formoterol

Sponsor

Mundipharma Research Limited